Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / APLIF - Appili receives regulatory clearance to expand mid-stage of Favipiravir for COVID-19

APLIF - Appili receives regulatory clearance to expand mid-stage of Favipiravir for COVID-19

Appili Therapeutics Inc
  • The FDA has signed off on Appili Therapeutics's (OTCQX:APLIF) Investigational New Drug (IND) application for its broad-spectrum antiviral favipiravir for COVID-19.
  • More news on: Appili Therapeutics Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Appili Therapeutics Inc
Stock Symbol: APLIF
Market: OTC
Website: appilitherapeutics.com
Menu
APLIF APLIF Quote APLIF Short APLIF News APLIF Articles APLIF Message Board
Get APLIF Alerts

News, Short Squeeze, Breakout and More Instantly...